Reynolds LM et al. |
Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. |
2001 |
Neurosci. Lett. |
pmid:11514074
|
Gazzah N et al. |
Evidence for brain docosahexaenoate recycling in the free-moving adult rat: implications for measurement of phospholipid synthesis. |
1994 |
Neurosci. Lett. |
pmid:7824158
|
Wang X et al. |
Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. |
2003 |
Neuroreport |
pmid:14663210
|
Wu A et al. |
Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. |
2014 |
Neurorehabil Neural Repair |
pmid:23911971
|
Baldessarini RJ et al. |
Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat. |
2001 |
Neuropsychopharmacology |
pmid:11106876
|
Ethier I et al. |
The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. |
2004 |
Neuropsychopharmacology |
pmid:14603264
|
Lu DY et al. |
Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. |
2010 |
Neuropsychopharmacology |
pmid:20668435
|
Molloy C et al. |
Docosahexaenoic acid and visual functioning in preterm infants: a review. |
2012 |
Neuropsychol Rev |
pmid:23065239
|
Tamim MK et al. |
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. |
2010 |
Neuropharmacology |
pmid:19576910
|
Poling JS et al. |
Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. |
1996 |
Neuropharmacology |
pmid:8938727
|
Bate C et al. |
Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. |
2008 |
Neuropharmacology |
pmid:18355880
|
Li Z et al. |
Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. |
2006 |
Neuropharmacology |
pmid:16895729
|
Suganuma H et al. |
Maternal docosahexaenoic acid-enriched diet prevents neonatal brain injury. |
2010 |
Neuropathology |
pmid:20408962
|
Zhao Z and Zlokovic BV |
Blood-brain barrier: a dual life of MFSD2A? |
2014 |
Neuron |
pmid:24853933
|
Mucke L and Pitas RE |
Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. |
2004 |
Neuron |
pmid:15339638
|
Calon F et al. |
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. |
2004 |
Neuron |
pmid:15339646
|
Dyall SC and Michael-Titus AT |
Neurological benefits of omega-3 fatty acids. |
2008 |
Neuromolecular Med. |
pmid:18543124
|
Ammann EM et al. |
ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. |
2013 |
Neurology |
pmid:24068783
|
Martinez M and Vazquez E |
MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. |
1998 |
Neurology |
pmid:9674774
|
MartÃnez M |
Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? |
1990 |
Neurology |
pmid:2143272
|
Pottala JV et al. |
Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. |
2014 |
Neurology |
pmid:24453077
|
Paker AM et al. |
Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. |
2010 |
Neurology |
pmid:20805528
|
Martinez M et al. |
Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases. |
1993 |
Neurology |
pmid:8327143
|
Ajami M et al. |
Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats. |
2011 |
Neurol. Sci. |
pmid:21617951
|
Narita K et al. |
Therapeutic time window in the penumbra during permanent focal ischemia in rats: changes of free fatty acids and glycerophospholipids. |
2000 |
Neurol. Res. |
pmid:10874689
|
Jones CR et al. |
Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. |
1997 |
Neurochem. Res. |
pmid:9178948
|
Ikemoto A et al. |
Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. |
1997 |
Neurochem. Res. |
pmid:9178949
|
Halapin NA and Bazan NG |
NPD1 induction of retinal pigment epithelial cell survival involves PI3K/Akt phosphorylation signaling. |
2010 |
Neurochem. Res. |
pmid:21136150
|
Lee HJ et al. |
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. |
2005 |
Neurochem. Res. |
pmid:16176072
|
Prasad MR et al. |
Regional membrane phospholipid alterations in Alzheimer's disease. |
1998 |
Neurochem. Res. |
pmid:9482271
|
Chang MC et al. |
Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. |
1999 |
Neurochem. Res. |
pmid:10215514
|
Machová E et al. |
The increase of choline acetyltransferase activity by docosahexaenoic acid in NG108-15 cells grown in serum-free medium is independent of its effect on cell growth. |
2006 |
Neurochem. Res. |
pmid:17004129
|
Alvarez-Nölting R et al. |
Protection by DHA of early hippocampal changes in diabetes: possible role of CREB and NF-κB. |
2012 |
Neurochem. Res. |
pmid:21909958
|
Orr SK et al. |
The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. |
2010 |
Neurochem. Res. |
pmid:20177777
|
Brown J et al. |
Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA). |
2009 |
Neurochem. Res. |
pmid:18592376
|
Kabuto H et al. |
Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. |
2009 |
Neurochem. Res. |
pmid:19219632
|
de Turco EB et al. |
Strong association of unesterified [3H]docosahexaenoic acid and [3H-docosahexaenoyl]phosphatidate to rhodopsin during in vivo labeling of frog retinal rod outer segments. |
2000 |
Neurochem. Res. |
pmid:10905632
|
Martin RE et al. |
Uptake and incorporation of docosahexaenoic acid (DHA) into neuronal cell body and neurite/nerve growth cone lipids: evidence of compartmental DHA metabolism in nerve growth factor-differentiated PC12 cells. |
2000 |
Neurochem. Res. |
pmid:10905634
|
Terrian DM et al. |
Glutamate is the endogenous amino acid selectively released by rat hippocampal mossy fiber synaptosomes concomitantly with prodynorphin-derived peptides. |
1990 |
Neurochem. Res. |
pmid:1970130
|
Dagai L et al. |
Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth. |
2009 |
Neurochem. Res. |
pmid:18781386
|
Hashimoto M et al. |
Prescription n-3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. |
2013 |
Neurochem. Res. |
pmid:23963508
|
Fraser T et al. |
Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. |
2010 |
Neurochem. Res. |
pmid:19904605
|
Petroni A et al. |
Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells. |
1994 |
Neurochem. Res. |
pmid:7824073
|
Giesing M and Zilliken F |
Lipid metabolism of developing central nervous tissues in organotypic cultures. III. Ganglionic control of glycerolipids and fatty acids in cortex grey matter. |
1980 |
Neurochem. Res. |
pmid:6445512
|
Schonfeld E et al. |
Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells. |
2007 |
Neurochem. Res. |
pmid:17551831
|
Ouellet M et al. |
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. |
2009 |
Neurochem. Int. |
pmid:19442696
|
Ozsoy O et al. |
The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease. |
2011 |
Neurochem. Int. |
pmid:21736911
|
Cieslik M et al. |
Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment. |
2013 |
Neurochem. Int. |
pmid:23439385
|
Julien C et al. |
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. |
2006 |
Neurochem. Int. |
pmid:16442670
|
Grintal B et al. |
Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. |
2009 |
Neurochem. Int. |
pmid:19428799
|
Boudrault C et al. |
Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice. |
2010 |
Neurochem. Int. |
pmid:20064570
|
Rosenberger TA et al. |
Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. |
2010 |
Neurochem. Int. |
pmid:20026368
|
Mathieu G et al. |
DHA enhances the noradrenaline release by SH-SY5Y cells. |
2010 |
Neurochem. Int. |
pmid:19770016
|
Mahmoudi S et al. |
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid. |
2009 |
Neurobiol. Dis. |
pmid:19635563
|
De Felice C et al. |
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. |
2014 |
Neurobiol. Dis. |
pmid:24769161
|
Hooijmans CR et al. |
Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). |
2007 |
Neurobiol. Dis. |
pmid:17720508
|
Hooijmans CR et al. |
DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. |
2009 |
Neurobiol. Dis. |
pmid:19130883
|
Eady TN et al. |
Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats. |
2014 |
Neurobiol. Dis. |
pmid:24063996
|
Oksman M et al. |
Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. |
2006 |
Neurobiol. Dis. |
pmid:16765602
|
Norris SE et al. |
Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease. |
2015 |
Neurobiol. Aging |
pmid:25676385
|
Favrelère S et al. |
Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. |
2000 Sep-Oct |
Neurobiol. Aging |
pmid:11016534
|
Stough C et al. |
The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. |
2012 |
Neurobiol. Aging |
pmid:21531481
|
Robson LG et al. |
Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. |
2010 |
Neurobiol. Aging |
pmid:18620782
|
Wang DC et al. |
Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. |
2012 |
Neurobiol. Aging |
pmid:20980076
|
Walhovd KB et al. |
Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging. |
2014 |
Neurobiol. Aging |
pmid:24332985
|
Favrelière S et al. |
DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. |
2003 Mar-Apr |
Neurobiol. Aging |
pmid:12498957
|
Marin R et al. |
Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases. |
2017 |
Neurobiol. Aging |
pmid:27768960
|
Hacioglu G et al. |
Beneficial effects of docosahexaenoic acid on active avoidance performance in 1K-1C hypertensive rats. |
2007 |
Neurobiol Learn Mem |
pmid:16979916
|
Vasickova L et al. |
Possible effect of DHA intake on body weight reduction and lipid metabolism in obese children. |
2011 |
Neuro Endocrinol. Lett. |
pmid:22101886
|
Mincke E et al. |
Lower omega-3 polyunsaturated fatty acids and lower docosahexaenoic acid in men with pedophilia. |
2006 |
Neuro Endocrinol. Lett. |
pmid:17187003
|
Maes M et al. |
Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response. |
2007 |
Neuro Endocrinol. Lett. |
pmid:18063921
|
Mraz J et al. |
Culture of common carp (Cyprinus carpio) with defined flesh quality for prevention of cardiovascular diseases using finishing feeding strategy. |
2012 |
Neuro Endocrinol. Lett. |
pmid:23183512
|
Sliwinski S et al. |
Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? |
2006 |
Neuro Endocrinol. Lett. |
pmid:16891996
|
Turck D |
Later effects of breastfeeding practice: the evidence. |
2007 |
Nestle Nutr Workshop Ser Pediatr Program |
pmid:17664895
|
Michaelsen KF et al. |
Whole cow's milk: why, what and when? |
2007 |
Nestle Nutr Workshop Ser Pediatr Program |
pmid:17664906
|
Makrides M et al. |
Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth. |
2010 |
Nestle Nutr Workshop Ser Pediatr Program |
pmid:20139678
|
Bazan NG et al. |
Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system. |
2013 |
Nestle Nutr Inst Workshop Ser |
pmid:24107502
|
Scholtz SA et al. |
Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period. |
2013 |
Nestle Nutr Inst Workshop Ser |
pmid:24107504
|
Rylance PB et al. |
Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. |
1986 |
Nephron |
pmid:3724927
|
Beavers KM et al. |
Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. |
2008 |
Nephrology (Carlton) |
pmid:18331436
|
Huang X et al. |
Serum and adipose tissue fatty acid composition as biomarkers of habitual dietary fat intake in elderly men with chronic kidney disease. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23229929
|
Saifullah A et al. |
Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17623719
|
Ferraro PM et al. |
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. |
2009 |
Nephrol. Dial. Transplant. |
pmid:18685141
|
Chin HJ et al. |
Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. |
2010 |
Nephrol. Dial. Transplant. |
pmid:20042400
|
Cheng IK et al. |
The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis. |
1990 |
Nephrol. Dial. Transplant. |
pmid:2113220
|
van Acker BA et al. |
The effect of fish oil on lipid profile and viscosity of erythrocyte suspensions in CAPD patients. |
1987 |
Nephrol. Dial. Transplant. |
pmid:2831474
|
Hu Y et al. |
Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. |
2010 |
Neoplasia |
pmid:20927321
|
Lapillonne A et al. |
Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. |
2010 |
Neonatology |
pmid:21051909
|
Berman DR et al. |
Docosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia model. |
2013 |
Neonatology |
pmid:23817197
|
|
Docosahexaenoic and arachidonic acid levels in ELBW infants with prolonged exposure to intravenous lipids. |
2013 May-Jun |
Neonatal Netw |
pmid:23807965
|
Mitmesser SH and Jensen CL |
Roles of long-chain polyunsaturated fatty acids in the term infant: developmental benefits. |
2007 Jul-Aug |
Neonatal Netw |
pmid:17710956
|
Korstanje MJ et al. |
[Fish oil; from food to medicine?]. |
1991 |
Ned Tijdschr Geneeskd |
pmid:1828538
|
Gavzan H et al. |
Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models. |
2015 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:26018398
|
Reithmann C et al. |
Exposure to the n-3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1-adrenoceptor-mediated contractile responses and inositol phosphate formation in rat cardiomyocytes. |
1996 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8857587
|
Itoh T and Yamamoto K |
Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand. |
2008 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:18193404
|
Dhein S et al. |
Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. |
2005 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:15900514
|
Turner N et al. |
Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. |
2003 |
Naturwissenschaften |
pmid:14610651
|
Serhan CN |
Pro-resolving lipid mediators are leads for resolution physiology. |
2014 |
Nature |
pmid:24899309
|
Swinbanks D |
Fish-oil miracle additive brings benefits to some. |
1993 |
Nature |
pmid:8321302
|
Chiang N et al. |
Infection regulates pro-resolving mediators that lower antibiotic requirements. |
2012 |
Nature |
pmid:22538616
|